Our ability to deliver on our promise to develop novel therapies with high clinical value begins with our experienced, passionate team. Leadiant Biosciences, Inc., is led by a team of experienced pharmaceutical executives who share a common purpose: helping people affected by rare diseases. The team’s collective knowledge and unrivaled expertise in orphan drug development guides our research, development, and delivery of crucial therapies to patients who need them most.
Giuseppe Izzi
Chief Executive Officer
Mr. Izzi is the Chief Executive Officer of Leadiant Biosciences, Inc. Mr. Izzi has more than 20 years of financial experience and was previously the Vice President, Administration and Chief Financial Officer of Leadiant Biosciences, Inc. and the Financial Director for Sigma-Tau España based in Madrid, Spain.
Prior to joining Leadiant, he was an executive director with a major accounting firm, providing consulting services in capital market transactions, acquisitions and audit. Mr. Izzi received a bachelor’s degree in economics from the Università degli Studi di Roma ‘La Sapienza’.
Giuseppe D. Testa
Vice President, Product Development
Mr. Testa is Vice President, Product Development at Leadiant Biosciences, Inc., and is responsible for strategic and operational oversight of the development of novel therapeutics in clinical research. He has more than 30 years of experience in research and clinical development including trial planning and implementation, as well as project management, staff recruiting and training. His therapeutic experiences include cardiovascular, oncology and neurology, as well as immunology.
Mr. Testa first joined Leadiant Biosciences, Inc., in 1987, serving as the Clinical Research Associate for the International Clinical Trials Division in Research & Development in Italy. In 1997, he transferred to the U.S. and most recently served as the Vice President of Clinical Development. Prior to that, Mr. Testa held a variety of positions with increasing responsibility within the company.
Mr. Testa holds a Bachelor of Arts from the Università degli Studi di Roma ‘La Sapienza’.
